None listed
Conditions
Brief summary
Elinogrel is under development for the treatment of patients with chronic coronary heart disease and acute coronary syndromes. Patients treated for these conditions are likley to be on a statin therapy such as atorvastatin in addition to other anticoagulants such as elinogrel. Hence the need to investigate the potential drug-drug interaction between elinogrel and atorvastatin.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
- adult subjects aged 18 to 45 - Body Mass Index (BMI) between 18 and 32 Kg/m2 - Change between seated and standing blood pressure less than 20 mmHg for systolic blood pressure and 10 mmHg for diastolic blood pressure.
Exclusion criteria
- Women of childbearing potential unless using suitable contraception methods - Bleeding time tests out of normal laboratory range - Abnormal liver function test results - Other protocol-defined inclusion/exclusion criteria may apply